These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 418531)

  • 1. Antiallergic chromones. I. Disposition of 5-(3-p-cyanophenoxy-2-hydroxy-1-propoxy)-2-(1H-tetrazol-5-yl) chromone in four mammalian species.
    Muni IA; Leeling JL; Helms RJ; Johnson N
    Toxicol Appl Pharmacol; 1978 Mar; 43(3):527-34. PubMed ID: 418531
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic disposition of 6-ethyl-3-(1H-tetrazol-5-yl)-chromone, a new antiallergic agent, in the rat, guinea-pig, rabbit, dog and monkey.
    Kanai Y; Nakai Y; Nakajima N; Tanayama S
    Xenobiotica; 1979 Jan; 9(1):33-50. PubMed ID: 104449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on antianaphylactic agents. 6. Synthesis of some metabolites of 6-ethyl-3-(1H-tetrazol-5-yl)chromone and their analogues.
    Nohara A; Kuriki H; Ishiguro T; Saijo T; Ukawa K; Maki Y; Sanno Y
    J Med Chem; 1979 Mar; 22(3):290-5. PubMed ID: 423211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on antianaphylactic agents. 5. Synthesis of 3-(1H-tetrazol-5-yl)chromones, a new series of antiallergic substances.
    Nohara A; Kuriki H; Saijo T; Sugihara H; Kanno M; Sanno Y
    J Med Chem; 1977 Jan; 20(1):141-5. PubMed ID: 13214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiallergic action of 6-ethyl-3-(1h-tetrazol-5-YL) chromone (AA-344) on immediate hypersensitivity reaction in rats.
    Kuriki H; Saijo T; Maki Y; Kanno M
    Jpn J Pharmacol; 1979 Jun; 29(3):385-97. PubMed ID: 43912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-bu tyric acid.
    Kuriyama K; Hiyama Y; Ito K
    Jpn J Pharmacol; 1989 Jun; 50(2):111-8. PubMed ID: 2475659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and quantitative structure-activity relationships of antiallergic 2-hydroxy-N-1H-tetrazol-5-ylbenzamides and N-(2-hydroxyphenyl)-1H-tetrazole-5-carboxamides.
    Ford RE; Knowles P; Lunt E; Marshall SM; Penrose AJ; Ramsden CA; Summers AJ; Walker JL; Wright DE
    J Med Chem; 1986 Apr; 29(4):538-49. PubMed ID: 2870188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in toxicity due to species variation in the metabolism of an oral anti-allergy agent [proceedings].
    Smith DA
    Br J Pharmacol; 1979 Jul; 66(3):422P-423P. PubMed ID: 43174
    [No Abstract]   [Full Text] [Related]  

  • 9. The disposition of FPL 55712 acid (7-[3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-2-hydroxypropoxy)-4-oxo-8 propyl-4H-benzopyran-2-carboxylic acid) in rat and dog.
    Mead B; Patterson LH; Smith DA
    J Pharm Pharmacol; 1981 Oct; 33(10):682-4. PubMed ID: 6117630
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution and metabolism of disodium cromoglycate in rats.
    Moss GF; Jones KM; Ritchie JT; Cox JS
    Toxicol Appl Pharmacol; 1970 Nov; 17(3):691-8. PubMed ID: 4681803
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone sodium salt (MDL 427): a new antiallergic agent.
    Peet NP; Baugh LE; Sunder S; Lewis JE; Matthews EH; Olberding EL; Shah DN
    J Med Chem; 1986 Nov; 29(11):2403-9. PubMed ID: 2431144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absorption, excretion and metabolism of disodium (14C)cromoglycate in man.
    Walker SR; Richards AJ; Paterson JW
    Biochem J; 1971 Nov; 125(2):27P. PubMed ID: 5004195
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromone-2-carboxylic acids: roles of acidity and lipophilicity in drug disposition.
    Smith DA; Brown K; Neale MG
    Drug Metab Rev; 1985-1986; 16(4):365-88. PubMed ID: 3915471
    [No Abstract]   [Full Text] [Related]  

  • 14. 6,8-Di-t-butyl-4-oxo-4H-1-benzopyran-2-carboxylic acid: a chromone derivative with anti-allergic, anti-inflammatory and uricosuric activity.
    Augstein J; Cairns H; Chambers A; Burns JW; Radziwonik H
    J Pharm Pharmacol; 1976 Dec; 28(12):919-20. PubMed ID: 12270
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory action of 6-ethyl-3-(1H-tetrazol-5-YL)chromone (AA-344) on IgE, IgGa- or chemical agent-induced histamine release from isolated rat mast cells.
    Saijo T; Ashida Y; Kuriki H; Kanno M; Maki Y
    Jpn J Pharmacol; 1979 Aug; 29(4):531-40. PubMed ID: 94114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical assessment of the absorption and disposition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor GDC-0980 and prediction of its pharmacokinetics and efficacy in human.
    Salphati L; Pang J; Plise EG; Lee LB; Olivero AG; Prior WW; Sampath D; Wong S; Zhang X
    Drug Metab Dispos; 2012 Sep; 40(9):1785-96. PubMed ID: 22696419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Cazes M; Provost D; Versigny A; Cloarec A
    Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 6-ethyl-3-(1H-tetrazol-5-yl)chromone (AA-344) on the immediate and delayed hypersensitivity reactions.
    Kuriki H; Saijo T; Ashida Y; Maki Y
    Jpn J Pharmacol; 1979 Oct; 29(5):733-44. PubMed ID: 161338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absorption and clearance of disodium cromoglycate from the lung in rat, rabbit, and monkey.
    Moss GF; Ritchie JT
    Toxicol Appl Pharmacol; 1970 Nov; 17(3):699-707. PubMed ID: 4993036
    [No Abstract]   [Full Text] [Related]  

  • 20. Cinnoline-3-propionic acids, a new series of orally active antiallergic substances.
    Holland D; Jones G; Marshall PW; Tringham GD
    J Med Chem; 1976 Oct; 19(10):1225-8. PubMed ID: 825646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.